Page last updated: 2024-10-24

1-o-hexadecyl-2-n-methylcarbamylphosphatidylcholine and Acquired-Immune Deficiency Syndrome Dementia Complex

1-o-hexadecyl-2-n-methylcarbamylphosphatidylcholine has been researched along with Acquired-Immune Deficiency Syndrome Dementia Complex in 1 studies

1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine: biologically active analog of PAF; structure given in first source

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellizzi, MJ1
Lu, SM1
Masliah, E1
Gelbard, HA1

Other Studies

1 other study available for 1-o-hexadecyl-2-n-methylcarbamylphosphatidylcholine and Acquired-Immune Deficiency Syndrome Dementia Complex

ArticleYear
Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor.
    The Journal of clinical investigation, 2005, Volume: 115, Issue:11

    Topics: AIDS Dementia Complex; Animals; Calcium; Caspases; Dendritic Spines; Electric Stimulation; Hippocamp

2005